Medibiofarma S L
2 known investors
Find your way into Medibiofarma S L
Sign up to see every warm intro you have to Medibiofarma S L
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medibiofarma S L team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medibiofarma develops novel therapeutic treatments, including assets advancing into areas such as women's health and oncology. The company is associated with the launch of Oriva Therapeutics and licensing of assets originating from Oncostellae.
Investors · 2
Frequently asked questions
- What does Medibiofarma S L do?
- Medibiofarma develops novel therapeutic treatments, including assets advancing into areas such as women's health and oncology. The company is associated with the launch of Oriva Therapeutics and licensing of assets originating from Oncostellae.
- Who are Medibiofarma S L's investors?
- Medibiofarma S L's investors include Asabys Partners, Inveready Technology Investment Group.

